Female fertility loss and preservation: Threats and opportunities

Annals of Oncology

Volumn 24, Issue 3, 2013, Pages 598-608

  Salama, M ^a   Winkler, K ^a   Murach, K F ^a   Seeber, B ^a   Ziehr, S C ^a   Wildt, L ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Autotransplantation; Cancer; Cryopreservation; Fertility preservation; In vitro maturation; Ovary

Indexed keywords

ANTHRACYCLINE; BLEOMYCIN; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GONADORELIN DERIVATIVE; IRINOTECAN; METHOTREXATE; MONOCLONAL ANTIBODY; OXALIPLATIN; PREDNISONE; PROTEIN TYROSINE KINASE INHIBITOR; RITUXIMAB; VINBLASTINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; AGING; AUTOTRANSPLANTATION; AWARENESS; CANCER CHEMOTHERAPY; CANCER SURVIVOR; CELL CULTURE; CRYOPRESERVATION; DISEASE REGISTRY; EMBRYO FREEZING; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; HUMAN; MULTIPLE CYCLE TREATMENT; NONHUMAN; OOCYTE; OOCYTE CRYOPRESERVATION; OVARIAN TISSUE CRYOPRESERVATION; OVARY; OVARY FOLLICLE; OVARY PROTECTION; PATIENT COUNSELING; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; PROTECTION; REVIEW; TISSUE CULTURE;

AGING; ANTINEOPLASTIC AGENTS; BLASTOCYST; CRYOPRESERVATION; FEMALE; FERTILITY PRESERVATION; HUMANS; INFERTILITY, FEMALE; NEOPLASMS; OOCYTES; OVARY; TISSUE CULTURE TECHNIQUES;

EID: 84874562482     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds514     Document Type: Review

References (174)

1. Jemal A, Siegel R, Ward E et al Cancer statistics, 2009. CA Cancer J Clin 2009; 59(4): 225-249.
2. Ries LAG, Percy CL, Bunin GR. Introduction. In: Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds). Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995, National Cancer Institute, SEER program. Bethesda, MD: NIH Pub. No. 99-4649; 1999: 1-15.
3. Oktay K, Oktem O. Fertility preservation medicine: a new field in the care of young cancer survivors. Pediatr Blood Cancer 2009; 53(2): 267-273.
4. Maltaris T, Beckmann MW, Dittrich R. Fertility preservation for young female cancer patients. In Vivo 2009; 23(1): 123-130.
5. West ER, Zelinski MB, Kondapalli LA et al Preserving female fertility following cancer treatment: current options and future possibilities. Pediatr Blood Cancer 2009; 53(2): 289-295.
6. Coyne K, Kader A, Agarwal A. Creating a standard of care for fertility preservation. Curr Womens Health Rev 2010; 6(3): 261-266.
7. Baird DT, Collins J, Egozcue J et al. ESHRE Capri Workshop Group. Fertility and ageing. Hum Reprod Update 2005; 11(3): 261-276.
8. Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev 1996; 17(2): 121-155.
9. Lobo RA. Potential options for preservation of fertility in women. N Engl J Med 2005; 353(1): 64-73.
10. Shelling AN. Premature ovarian failure. Reproduction 2010; 140(5): 633-641.
11. Wallace WH, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol 2005; 6(4): 209-218.
12. Green DM, Sklar CA, Boice JD, Jr et al. Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study. J Clin Oncol 2009; 27(14): 2374-2381.
13. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 2001; 7(6): 534-543.
14. Maltaris T, Koelbl H, Seufert R et al Gonadal damage and options for fertility preservation in female and male cancer survivors. Asian J Androl 2006; 8(5): 515-533.
15. Stroud JS, Mutch D, Rader J et al Effects of cancer treatment on ovarian function. Fertil Steril 2009
16. Lee SJ, Schover LR, Partridge AH et al American Society of Clinical Oncology. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006; 24(18): 2917-2931.
17. Meirow D, Biederman H, Anderson RA et al Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol 2010; 53(4): 727-739.
18. Falcone T, Bedaiwy MA. Fertility preservation and pregnancy outcome after malignancy. Curr Opin Obstet Gynecol 2005; 63(11): 725-732.
19. Georgescu ES, Goldberg JM, du Plessis SS et al Present and future fertility preservation strategies for female cancer patients. Obstet Gynecol Surv 2008; 63 (11): 725-732.
20. Manger K, Wildt L, Kalden JR et al. Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study. Autoimmun Rev 2006; 5(4): 269-272.
21. Gidoni Y, Holzer H, Tulandi T et al. Fertility preservation in patients with nononcological conditions. Reprod Biomed Online 2008; 16(6): 792-800.
22. Elizur SE, Chian RC, Pineau CA et al. Fertility preservation treatment for young women with autoimmune diseases facing treatment with gonadotoxic agents. Rheumatology (Oxford) 2008; 47(10): 1506-1509.
23. Morris SN, Ryley D. Fertility preservation: nonsurgical and surgical options. Semin Reprod Med 2011; 29(2): 147-154.
24. Jensen JR, Morbeck DE, Coddington CC., III. Fertility preservation. Mayo Clin Proc 2011; 86(1): 45-49.
25. Woodruff TK. The Oncofertility Consortium-addressing fertility in young people with cancer. Nat Rev Clin Oncol 2010; 7(8): 466-475.
26. Smitz J, Dolmans MM, Donnez J et al. Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation. Hum Reprod Update 2010; 16(4): 395-414.
27. Silber SJ, Woodruff TK, Shea LD. To transplant or not to transplant that is the question. Cancer Treat Res 2010; 156: 41-54.
28. von Wolff M, Montag M, Dittrich R et al. Fertility preservation in women-a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT. Arch Gynecol Obstet 2011; 284(2): 427-435.
29. Edgar AB, Wallace WH. Pregnancy in women who had cancer in childhood. Eur J Cancer 2007; 43(13): 1890-1894.
30. Reulen RC, Zeegers MP, Wallace WH et al. Pregnancy outcomes among adult survivors of childhood cancer in the British Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev 2009; 18(8): 2239-2247.
31. Mueller BA, Chow EJ, Kamineni A et al. Pregnancy outcomes in female childhood and adolescent cancer survivors: a linked cancer-birth registry analysis. Arch Pediatr Adolesc Med 2009; 163(10): 879-886.
32. Williams RS, Littell RD, Mendenhall NP. Laparoscopic oophoropexy and ovarian function in the treatment of Hodgkin disease. Cancer 1999; 86(10): 2138-2142.
33. Morice P, Castaigne D, Haie-Meder C et al. Laparoscopic ovarian transposition for pelvic malignancies: indications and functional outcomes. Fertil Steril 1998; 70 (5): 956-960.
34. Morice P, Juncker L, Rey A et al. Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination. Fertil Steril 2000; 74(4): 743-748.
35. Han SS, Kim YH, Lee SH et al. Underuse of ovarian transposition in reproductiveaged cancer patients treated by primary or adjuvant pelvic irradiation. J Obstet Gynaecol Res 2011; 37(7): 825-829.
36. Molpus KL, Wedergren JS, Carlson MA. Robotically assisted endoscopic ovarian transposition. JSLS 2003; 7(1): 59-62.
37. Hadar H, Loven D, Herskovitz P et al. An evaluation of lateral and medial transposition of the ovaries out of radiation fields. Cancer 1994; 74(2): 774-779.
38. Bisharah M, Tulandi T. Laparoscopic preservation of ovarian function: an underused procedure. Am J Obstet Gynecol 2003; 188(2): 367-370.
39. Thibaud E, Ramirez M, Brauner R et al. Preservation of ovarian function by ovarian transposition performed before pelvic irradiation during childhood. J Pediatr 1992; 121(6): 880-884.
40. Terenziani M, Piva L, Meazza C et al. Oophoropexy: a relevant role in preservation of ovarian function after pelvic irradiation. Fertil Steril 2009; 91(3): 935. e15-935.e16.
41. Maltaris T, Beckmann MW, Binder H et al. The effect of a GnRH agonist on cryopreserved human ovarian grafts in severe combined immunodeficient mice. Reproduction 2007; 133(2): 503-509.
42. Clowse ME, Behera MA, Anders CK et al. Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. J Womens Health (Larchmt). 2009; 18 (3): 311-319.
43. Blumenfeld Z. How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries. Oncologist 2007; 12(9): 1044-1054.
44. Oktay K, Sonmezer M, Oktem O et al. Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury. Oncologist 2007; 12(9): 1055-1066.
45. Meistrich ML, Shetty G. Hormonal suppression for fertility preservation in males and females. Reproduction 2008; 136(6): 691-701.
46. Nitzschke M, Raddatz J, Bohlmann MK et al. GnRH analogs do not protect ovaries from chemotherapy-induced ultrastructural injury in Hodgkin's lymphoma patients. Arch Gynecol Obstet 2010; 282(1): 83-88.
47. Del Mastro L, Boni L, Michelotti A et al. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA 2011; 306(3): 269-276.
48. Chen H, Li J, Cui T et al. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women. Cochrane Database Syst Rev 2011; (11): CD008018.
49. Seli E, Tangir J. Fertility preservation options for female patients with malignancies. Curr Opin Obstet Gynecol 2005; 17(3): 299-308.
50. Dunn L, Fox KR. Techniques for fertility preservation in patients with breast cancer. Curr Opin Obstet Gynecol 2009; 21(1): 68-73.
51. Son WY, Yoon SH, Yoon HJ et al. Pregnancy outcome following transfer of human blastocysts vitrified on electron microscopy grids after induced collapse of the blastocoele. Hum Reprod 2003; 18(1): 137-139.
52. Wikland M, Hardarson T, Hillensjö T et al. Obstetric outcomes after transfer of vitrified blastocysts. Hum Reprod 2010; 25(7): 1699-1707.
53. Herrero L, Martínez M, Garcia-Velasco JA. Current status of human oocyte and embryo cryopreservation. Curr Opin Obstet Gynecol 2011; 23(4): 245-250.
54. Gosden R. Cryopreservation: a cold look at technology for fertility preservation. Fertil Steril 2011; 96(2): 264-268.
55. Saragusty J, Arav A. Current progress in oocyte and embryo cryopreservation by slow freezing and vitrification. Reproduction 2011; 141(1): 1-19.
56. Dolmans MM, Demylle D, Martinez-Madrid B et al. Efficacy of in vitro fertilization after chemotherapy. Fertil Steril 2005; 83(4): 897-901.
57. Stern CJ, Toledo MG, Gook DA et al. Fertility preservation in female oncology patients. Aust N Z J Obstet Gynaecol 2006; 46(1): 15-23.
58. Sönmezer M, Türkçüog? lu I, Coskun U et al. Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles. Fertil Steril 2011; 95(6): 2125.e9-2125.e11.
59. Gupta PB, Kuperwasser C. Contributions of estrogen to ER-negative breast tumor growth. J Steroid Biochem Mol Biol 2006; 102(1-5): 71-78.
60. Peña JE, Chang PL, Chan LK et al. Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles. Hum Reprod 2002; 17(1): 83-87.
61. Chen CH, Zhang X, Barnes R et al. Relationship between peak serum estradiol levels and treatment outcome in in vitro fertilization cycles after embryo transfer on day 3 or day 5. Fertil Steril 2003; 80(1): 75-79.
62. Oktay K. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation. J Clin Oncol 2005; 23(16): 3858-3859.
63. Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol 2008; 26(16): 2630-2635.
64. Oktay K, Buyuk E, Libertella N et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 2005; 23(19): 4347-4353.
65. Oktay K, Buyuk E, Davis O et al. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod 2003; 18(1): 90-95.
66. Cohen CB. Ethical issues regarding fertility preservation in adolescents and children. Pediatr Blood Cancer 2009; 53(2): 249-253.
67. Gong D, Liu YL, Zheng Z et al. An overview on ethical issues about sperm donation. Asian J Androl 2009; 11(6): 645-652.
68. Schenker JG. Assisted reproductive technology: perspectives in Halakha (Jewish religious law). Reprod Biomed Online 2008; 17(Suppl 3): 17-24.
69. Serour GI, Aboulghar MA, Mansour RT. Bioethics in medically assisted conception in the Muslim world. J Assist Reprod Genet 1995; 12(9): 559-565.
70. Baka SG, Toth TL, Veeck LL et al. Evaluation of the spindle apparatus of in-vitro matured human oocytes following cryopreservation. Hum Reprod 1995; 10(7): 1816-1820.
71. Pickering SJ, Braude PR, Johnson MH et al. Transient cooling to room temperature can cause irreversible disruption of the meiotic spindle in the human oocyte. Fertil Steril 1990; 54(1): 102-108.
72. Noyes N, Knopman J, Labella P et al. Oocyte cryopreservation outcomes including pre-cryopreservation and post-thaw meiotic spindle evaluation following slow cooling and vitrification of human oocytes. Fertil Steril 2010; 94(6): 2078-2082.
73. Fadini R, Brambillasca F, Renzini MM et al. Human oocyte cryopreservation: comparison between slow and ultrarapid methods. Reprod Biomed Online 2009; 19(2): 171-180.
74. Smith GD, Serafini PC, Fioravanti J et al. Prospective randomized comparison of human oocyte cryopreservation with slow-rate freezing or vitrification. Fertil Steril 2010; 94(6): 2088-2095.
75. Rienzi L, Romano S, Albricci L et al. Embryo development of fresh 'versus' vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study. Hum Reprod 2010; 25(1): 66-73.
76. Noyes N, Knopman JM, Melzer K et al. Oocyte cryopreservation as a fertility preservation measure for cancer patients. Reprod Biomed Online 2011; 23(3): 323-333.
77. Boldt J. Current results with slow freezing and vitrification of the human oocyte. Reprod Biomed Online 2011; 23(3): 314-322.
78. Levine J, Canada A, Stern CJ. Fertility preservation in adolescents and young adults with cancer. J Clin Oncol 2010; 28(32): 4831-4841.
79. Gosden RG. Prospects for oocyte banking and in vitro maturation. J Natl Cancer Inst Monogr 2005; 34: 60-63.
80. Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril 2006; 86(1): 70-80.
81. Porcu E, Bazzocchi A, Notarangelo L et al. Human oocyte cryopreservation in infertility and oncology. Curr Opin Endocrinol Diabetes Obes 2008; 15(6): 529-535.
82. Cobo A, Kuwayama M, Pérez S et al. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil Steril 2008; 89(6): 1657-1664.
83. Cobo A, Diaz C. Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril 2011; 96(2): 277-285.
84. Tao T, Zhang W, Del Valle A. Human oocyte cryopreservation. Curr Opin Obstet Gynecol 2009; 21(3): 247-252.
85. Rosendahl M, Schmidt KT, Ernst E et al. Cryopreservation of ovarian tissue for a decade in Denmark: a view of the technique. Reprod Biomed Online 2011; 22 (2): 162-171.
86. von Wolff M, Donnez J, Hovatta O et al. Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy a technique in its infancy but already successful in fertility preservation. Eur J Cancer 2009; 45(9): 1547-1553.
87. Isachenko E, Isachenko V, Nawroth F et al. Effect of long-term exposure at suprazero temperatures on activity and viability of human ovarian cortex. Fertil Steril 2009; 91(4 Suppl): 1556-1559.
88. Hovatta O. Methods for cryopreservation of human ovarian tissue. Reprod Biomed Online 2005; 10(6): 729-734.
89. Isachenko V, Lapidus I, Isachenko E et al. Human ovarian tissue vitrification versus conventional freezing: morphological, endocrinological, and molecular biological evaluation. Reproduction 2009; 138(2): 319-327.
90. Keros V, Xella S, Hultenby K et al. Vitrification versus controlled-rate freezing in cryopreservation of human ovarian tissue. Hum Reprod 2009; 24(7): 1670-1683.
91. Siebzehnrübl E, Kohl J, Dittrich R et al. Freezing of human ovarian tissue-not the oocytes but the granulosa is the problem. Mol Cell Endocrinol 2000; 169(1-2): 109-111.
92. Gook DA, Edgar DH, Borg J et al. Diagnostic assessment of the developmental potential of human cryopreserved ovarian tissue from multiple patients using xenografting. Hum Reprod 2005; 20(1): 72-78.
93. Maltaris T, Kaya H, Hoffmann I et al. Comparison of xenografting in SCID mice and LIVE/DEAD assay as a predictor of the developmental potential of cryopreserved ovarian tissue. In Vivo 2006; 20(1): 11-16.
94. Schubert B, Canis M, Darcha C et al. Follicular growth and estradiol follow-up after subcutaneous xenografting of fresh and cryopreserved human ovarian tissue. Fertil Steril 2008; 89(6): 1787-1794.
95. Demeestere I, Simon P, Emiliani S et al. Orthotopic and heterotopic ovarian tissue transplantation. Hum Reprod Update 2009; 15(6): 649-665.
96. Sonmezer M, Oktay K. Orthotopic and heterotopic ovarian tissue transplantation. Best Pract Res Clin Obstet Gynaecol 2010; 24(1): 113-126.
97. Donnez J, Dolmans MM. Cryopreservation and transplantation of ovarian tissue. Clin Obstet Gynecol 2010; 53(4): 787-796.
98. Donnez J, Silber S, Andersen CY et al. Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births. Ann Med 2011; 43(6): 437-450.
99. Revel A, Laufer N, Ben Meir A et al. Micro-organ ovarian transplantation enables pregnancy: a case report. Hum Reprod 2011; 26(5): 1097-1103.
100. Dittrich R, Lotz L, Keck G et al. Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil Steril 2012; 97 (2): 387-390.
101. Oktay K, Buyuk E, Veeck L et al. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 2004; 363(9412): 837-840.
102. Rosendahl M, Loft A, Byskov AG et al. Biochemical pregnancy after fertilization of an oocyte aspirated from a heterotopic autotransplant of cryopreserved ovarian tissue: case report. Hum Reprod 2006; 21(8): 2006-2009.
103. Lee DM, Yeoman RR, Battaglia DE et al. Live birth after ovarian tissue transplant. Nature 2004; 428(6979): 137-138.
104. Oktay K, Türkçüog? lu I, Rodriguez-Wallberg KA. Four spontaneous pregnancies and three live births following subcutaneous transplantation of frozen banked ovarian tissue: what is the explanation?. Fertil Steril 2011; 95(2): 804.e7-804.e10.
105. Meirow D, Hardan I, Dor J et al. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod 2008; 23(5): 1007-1013.
106. Rosendahl M, Andersen MT, Ralfkiær E et al. Evidence of residual disease in cryopreserved ovarian cortex from female patients with leukemia. Fertil Steril 2010; 94(6): 2186-2190.
107. Rosendahl M, Timmermans Wielenga V, Nedergaard L et al. Cryopreservation of ovarian tissue for fertility preservation: no evidence of malignant cell contamination in ovarian tissue from patients with breast cancer. Fertil Steril 2011; 95(6): 2158-2161.
108. Silber SJ, DeRosa M, Pineda J et al. A series of monozygotic twins discordant for ovarian failure: ovary transplantation (cortical versus microvascular) and cryopreservation. Hum Reprod 2008; 23(7): 1531-1537.
109. Yang H, Heun Lee H, Chang Lee H et al. Assessment of vascular endothelial growth factor expression and apoptosis in the ovarian graft: can exogenous gonadotropin promote angiogenesis after transplantation? Fertil Steril 2008; 90(4 Suppl): 1550-1558.
110. Rahimi G, Isachenko V, Kreienberg R et al. Re-vascularisation in human ovarian tissue after conventional freezing or vitrification and xenotransplantation. Eur J Obstet Gynecol Reprod Biol 2010; 149(1): 63-67.
111. Van Eyck AS, Bouzin C, Feron O et al. Both host and graft vessels contribute to revascularization of xenografted human ovarian tissue in a murine model. Fertil Steril 2010; 93(5): 1676-1685.
112. Imhof M, Bergmeister H, Lipovac M et al. Orthotopic microvascular reanastomosis of whole cryopreserved ovine ovaries resulting in pregnancy and live birth. Fertil Steril 2006; 85(Suppl 1): 1208-1215.
113. Imhof M, Hofstetter G, Bergmeister H et al. Cryopreservation of a whole ovary as a strategy for restoring ovarian function. J Assist Reprod Genet 2004; 21(12): 459-465.
114. Bedaiwy MA, Hussein MR, Biscotti C et al. Cryopreservation of intact human ovary with its vascular pedicle. Hum Reprod 2006; 21(12): 3258-3269.
115. Qi S, Ma A, Xu D et al. Cryopreservation of vascularized ovary: an evaluation of histology and function in rats. Microsurgery 2008; 28(5): 380-386.
116. Salle B, Demirci B, Franck M et al. Normal pregnancies and live births after autograft of frozen-thawed hemiovaries into ewes. Fertil Steril 2002; 77(2): 403-408.
117. Courbiere B, Caquant L, Mazoyer C et al. Difficulties improving ovarian functional recovery by microvascular transplantation and whole ovary vitrification. Fertil Steril 2009; 91(6): 2697-2706.
118. Zhang JM, Sheng Y, Cao YZ et al. Cryopreservation of whole ovaries with vascular pedicles: vitrification or conventional freezing? J Assist Reprod Genet 2011; 28(5): 445-452.
119. Bedaiwy MA, Shahin AY, Falcone T. Reproductive organ transplantation: advances and controversies. Fertil Steril 2008; 90(6): 2031-2055.
120. Silber S, Kagawa N, Kuwayama M et al. Duration of fertility after fresh and frozen ovary transplantation. Fertil Steril 2010; 94(6): 2191-2196.
121. Telfer EE, McLaughlin M. In vitro development of ovarian follicles. Semin Reprod Med 2011; 29(1): 15-23.
122. Brännström M, Milenkovic M. Advances in fertility preservation for female cancer survivors. Nat Med 2008; 14(11): 1182-1184.
123. Picton HM, Harris SE, Muruvi W et al. The in vitro growth and maturation of follicles. Reproduction 2008; 136(6): 703-715.
124. Telfer EE, McLaughlin M, Ding C et al. A two-step serum-free culture system supports development of human oocytes from primordial follicles in the presence of activin. Hum Reprod 2008; 23(5): 1151-1158.
125. Telfer EE, McLaughlin M, Keros V et al. Accelerated development of primordial follicles from vitrified human ovarian tissue within a two-step serum free culture system. Hum Reprod 2008; 23: 97.
126. Rahimi G, Isachenko E, Sauer H et al. Measurement of apoptosis in long-term cultures of human ovarian tissue. Reproduction 2001; 122(4): 657-663.
127. Hovatta O, Silye R, Abir R et al. Extracellular matrix improves survival of both stored and fresh human primordial and primary ovarian follicles in long-term culture. Hum Reprod 1997; 12(5): 1032-1036.
128. Isachenko V, Isachenko E, Reinsberg J et al. Cryopreservation of human ovarian tissue: comparison of rapid and conventional freezing. Cryobiology 2007; 55(3): 261-268.
129. Garor R, Abir R, Erman A et al. Effects of basic fibroblast growth factor on in vitro development of human ovarian primordial follicles. Fertil Steril 2009; 91(5 Suppl): 1967-1975.
130. Scott JE, Carlsson IB, Bavister BD et al. Human ovarian tissue cultures: extracellular matrix composition, coating density and tissue dimensions. Reprod Biomed Online 2004; 9(3): 287-293.
131. Otala M, Erkkilä K, Tuuri T et al. Cell death and its suppression in human ovarian tissue culture. Mol Hum Reprod 2002; 8(3): 228-236.
132. Kedem A, Hourvitz A, Fisch B et al. Alginate scaffold for organ culture of cryopreserved-thawed human ovarian cortical follicles. J Assist Reprod Genet 2011; 28(9): 761-769.
133. Ksiazkiewicz LK. Recent achievements in in vitro culture and preservation of ovarian follicles in mammals. Reprod Biol 2006; 6(1): 3-16.
134. Smitz JE, Cortvrindt RG. The earliest stages of folliculogenesis in vitro. Reproduction 2002; 123(2): 185-202.
135. Fabbri R, Pasquinelli G, Keane D et al. Culture of cryopreserved ovarian tissue: state of the art in 2008. Fertil Steril 2009; 91(5): 1619-1629.
136. Eppig JJ, O'Brien MJ. Development in vitro of mouse oocytes from primordial follicles. Biol Reprod 1996; 54(1): 197-207.
137. O'Brien MJ, Pendola JK, Eppig JJ. A revised protocol for in vitro development of mouse oocytes from primordial follicles dramatically improves their developmental competence. Biol Reprod 2003; 68(5): 1682-1686.
138. Liu J, van der Elst J, van den Broecke R et al. Live offspring by in vitro fertilization of oocytes from cryopreserved primordial mouse follicles after sequential in vivo transplantation and in vivo maturation. Biol Reprod 2001; 64 (1): 171-178.
139. Segino M, Ikeda M, Hirahara F et al. In vitro follicular development of cryopreserved mouse ovarian tissue. Reproduction 2005; 130(2): 187-192.
140. Choi J, Lee B, Lee E et al. Effect of activin A and insulin-like growth factor-I on in vitro development of preantral follicles isolated from cryopreserved ovarian tissues in the mouse. Cryobiology 2008; 57(3): 209-215.
141. Xu J, Lawson MS, Yeoman RR et al. Secondary follicle growth and oocyte maturation during encapsulated three-dimensional culture in rhesus monkeys: effects of gonadotrophins, oxygen and fetuin. Hum Reprod 2011; 26(5): 1061-1072.
142. Xu M, Fazleabas AT, Shikanov A et al. In vitro oocyte maturation and preantral follicle culture from the luteal-phase baboon ovary produce mature oocytes. Biol Reprod 2011; 84(4): 689-697.
143. Xu M, Barrett SL, West-Farrell E et al. In vitro grown human ovarian follicles from cancer patients support oocyte growth. Hum Reprod 2009; 24(10): 2531-2540.
144. Amorim CA, van Langendonckt A, David A et al. Survival of human pre-antral follicles after cryopreservation of ovarian tissue, follicular isolation and in vitro culture in a calcium alginate matrix. Hum Reprod 2009; 24(1): 92-99.
145. Desai N, Alex A, AbdelHafez F et al. Three-dimensional in vitro follicle growth: overview of culture models, biomaterials, design parameters and future directions. Reprod Biol Endocrinol 2010; 8: 119.
146. Albertini DF, Akkoyunlu G. Ovarian follicle culture systems for mammals. Methods Enzymol 2010; 476: 107-121.
147. Kreeger PK, Deck JW, Woodruff TK et al. The in-vitro regulation of ovarian follicle development using alginate-extracellular matrix gels. Biomaterials 2006; 27(5): 714-723.
148. Woodruff TK, Shea LD. The role of the extracellular matrix in ovarian follicle development. Reprod Sci 2007; 14(8 Suppl): 6-10.
149. West ER, Shea LD, Woodruff TK. Engineering the follicle microenvironment. Semin Reprod Med 2007; 25(4): 287-299.
150. Smith RM, Woodruff TK, Shea LD. Designing follicle-environment interactions with biomaterials. Cancer Treat Res 2010; 156: 11-24.
151. Huang JY, Tulandi T, Holzer H et al. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril 2008; 89 (3): 567-572.
152. Cao YX, Chian RC. Fertility preservation with immature and in vitro matured oocytes. Semin Reprod Med 2009; 27(6): 456-464.
153. Bocca S, Dedmond D, Jones E et al. Successful extracorporeal mature oocyte harvesting after laparoscopic oophorectomy following controlled ovarian hyperstimulation for the purpose of fertility preservation in a patient with borderline ovarian tumor. J Assist Reprod Genet 2011; 28(9): 771-772.
154. Sirard MA. Follicle environment and quality of in vitro matured oocytes. J Assist Reprod Genet 2011; 28(6): 483-488.
155. Smitz JE, Thompson JG, Gilchrist RB. The promise of in vitro maturation in assisted reproduction and fertility preservation. Semin Reprod Med 2011; 29(1): 24-37.
156. Huang JY, Chian RC, Tan SL. Ovarian hyperstimulation syndrome prevention strategies: in vitro maturation. Semin Reprod Med 2010; 28(6): 519-531.
157. Ata B, Shalom-Paz E, Chian RC et al. In vitro maturation of oocytes as a strategy for fertility preservation. Clin Obstet Gynecol 2010; 53(4): 775-786.
158. Chian RC. In-vitro maturation of immature oocytes for infertile women with PCOS. Reprod Biomed Online 2004; 8(5): 547-552.
159. Demirtas E, Elizur SE, Holzer H et al. Immature oocyte retrieval in the luteal phase to preserve fertility in cancer patients. Reprod Biomed Online 2008; 17(4): 520-523.
160. Bedoschi GM, de Albuquerque FO, Ferriani RA et al. Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature. J Assist Reprod Genet 2010; 27(8): 491-494.
161. Maman E, Meirow D, Brengauz M et al. Luteal phase oocyte retrieval and in vitro maturation is an optional procedure for urgent fertility preservation. Fertil Steril 2011; 95(1): 64-67.
162. Chian RC, Lim JH, Tan SL. State of the art in in-vitro oocyte maturation. Curr Opin Obstet Gynecol 2004; 16(3): 211-219.
163. Jurema MW, Nogueira D. In vitro maturation of human oocytes for assisted reproduction. Fertil Steril 2006; 86(5): 1277-1291.
164. Söderström-Anttila V, Mäkinen S, Tuuri T et al. Favourable pregnancy results with insemination of in vitro matured oocytes from unstimulated patients. Hum Reprod 2005; 20(6): 1534-1540.
165. Chian RC, Huang JY, Gilbert L et al. Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes. Fertil Steril 2009; 91(6): 2391-2398.
166. Gardino SL, Emanuel LL. Choosing life when facing death: understanding fertility preservation decision-making for cancer patients. Cancer Treat Res 2010; 156: 447-458.
167. Woodruff TK. The emergence of a new interdiscipline: oncofertility. Cancer Treat Res 2007; 138: 3-11.
168. Rodriguez S. Placing the history of oncofertility. Cancer Treat Res 2010; 156: 103-110.
169. Gardino SL, Jeruss JS, Woodruff TK. Using decision trees to enhance interdisciplinary team work: the case of oncofertility. J Assist Reprod Genet 2010; 27(5): 227-231.
170. Redig AJ, Brannigan R, Stryker SJ et al. Incorporating fertility preservation into the care of young oncology patients. Cancer 2011; 117(1): 4-10.
171. Jungheim ES, Carson KR, Brown D. Counseling and consenting women with cancer on their oncofertility options: a clinical perspective. Cancer Treat Res 2010; 156: 403-412.
172. Asch A. The lessons of oncofertility for assisted reproduction. Cancer Treat Res 2010; 156: 181-186.
173. Lee SJ. ASCO Fertility Preservation Guidelines Committee. Preservation of fertility in patients with cancer. N Engl J Med 2009; 360(25): 2680; author reply 2682-2683.
174. Köhler TS, Kondapalli LA, Shah A et al. Results from the survey for preservation of adolescent reproduction (SPARE) study: gender disparity in delivery of fertility preservation message to adolescents with cancer. J Assist Reprod Genet 2011; 28(3): 269-277.